InvestorsHub Logo
Post# of 252903
Next 10
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: genisi post# 107672

Monday, 11/01/2010 1:57:16 PM

Monday, November 01, 2010 1:57:16 PM

Post# of 252903

Bayer said Xarelto had “comparable” safety and rates of bleeding versus the standard.

big question is bleeding rates. Were bleeding rates better for Xarelto and how do they compare to rates found in dabigatran RELY study. Guess we'll know by Nov. the 15th.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.